Topic

News

Time-sensitive clinical and regulatory news — FDA actions, CMS coverage decisions, new device clearances, drug approvals. Updated 2-3x per week.

1 article Last updated May 28, 2026

Wegovy Subscription Program: Novo Nordisk’s New Approach to Access

Reading Time: 4 minutesNovo Nordisk, the manufacturer of the popular GLP-1 medication Wegovy (semaglutide), has introduced a new multi-month subscription program designed to make this FDA-approved obesity treatment more accessible and affordable for self-pay patients...

April 6, 2026 · 5 min